Steris said its Isomedix subsidiary will pay up to $48.15 million to resolve litigation around an EtO sterilization facility ...

Steris shows strong AST growth and positive FY25 guidance. See why STE stock is upgraded to 'Strong Buy' with solid revenue ...

Valued at a market cap of $21.7 billion, STERIS plc (STE) is a provider of products and services that support patient care with an emphasis on infection prevention. Based in Mentor, Ohio, operates ...

STERIS currently trades at $226.40 per share and has shown little upside over the past six months, posting a small loss of ...

Last November, Steris disclosed in another SEC filing that Isomedix had been sued in Illinois state court "by individual plaintiffs who work or reside" near a facility in Waukegan, Illinois, a Chicago ...

STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization ...

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services ...

HighTower Advisors LLC cut its stake in shares of STERIS plc (NYSE:STE – Free Report) by 0.5% in the 4th quarter, ...

STERIS plc’s STE continues to thrive, fueled by strong procedure volume growth, favorable pricing and market share gains. The company is seeing early signs of increased bioprocessing demand, which is ...

STERIS is particularly gaining success with ethylene oxide (EO) sterilization. In the fiscal third quarter, the AST division experienced 10% reported growth year over year. This performance was ...

Avantax Advisory Services Inc. lowered its stake in shares of STERIS plc (NYSE:STE – Free Report) by 4.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & ...